A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
07/27/2021 | Sponsored by Epredia
Want to learn how to achieve IHC assays in 30 minutes and multiplex assays in 2.5 hours?
07/15/2021 | Sponsored by Canopy Biosciences
Understanding the complex spatial distribution of key immune cell populations in tumors is the next frontier in advancing our understanding of cancer to inform the development of novel therapeutics.
07/13/2021 | Sponsored by Paige
Come hear the latest on clinical-grade AI workflows from Paige.
06/10/2021 | Sponsored by FFEI
The latest thinking in the area of color fidelity in digital pathology.
05/31/2021 | Sponsored by Ultivue
The relevance to understand the entire tumor heterogeneity, its immune environment and contextual relationship requires the spatial quantification of different immune and tumor cells...
03/25/2021 | Sponsored by ContextVision
Dr Filippo Fraggetta shares his experience and clinical results of using INIFY Prostate Screening in the fully digitalized workflow at Cannizzaro hospital, Catania, Italy.
03/24/2021 | Sponsored by Bionano Genomics
In this webinar, Dr. Frances High will explore how she used Bionano’s Saphyr system for optical genome mapping to analyze structural variations in a large cohort of patients with CDH and their parents.
03/11/2021 | Sponsored by Thermo Fisher Scientific
In this webinar, our speakers will discuss the benefits of CGP and how this technique is utilized in their lab.
02/24/2021 | Sponsored by Aurora mScope Inc.
The field of digital pathology (DP) continues to see ongoing innovation, growth and development.
02/18/2021 | Sponsored by Akoya Biosciences
In this webinar, the speakers will describe how they used multiplexed imaging and single-cell analysis to study the immune response to the SARS-CoV-2 virus across multiple organ systems.
01/13/2021 | Sponsored by Akoya Biosciences
Optimisation and validation of a multiplex immunofluorescence workflow, from staining to digital image analysis, ensures assay robustness and prepares this technology for deployment in clinical trial analysis and in routine diagnostics.
12/14/2020 | Sponsored by Promega
Microsatellite Instability (MSI)-High has been identified as a biomarker for immune checkpoint inhibitor therapy in cancers originating in different tissues.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Cytology: the Backbone of Modern Pathology?
Real-Life Forensic Pathology Is Not CSI
The Lasting Legacy of SARS-CoV-2